Literature DB >> 19517208

[Dronedarone: the new antiarrythmic agent?].

J Brachmann1, A-M Sinha.   

Abstract

Dronedarone is recommended as the successor drug to amiodarone because a faster onset of effects and less side effects are to be expected. This review describes the pharmacological properties of this multi-channel blocker and summarizes the results from recent studies proving successful antiarrhythmic therapy using dronedarone in patients with atrial fibrillation.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19517208     DOI： 10.1007/s00399-009-0042-9

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN： 0938-7412


  16 in total

Review 1.  The novel antiarrhythmic drug dronedarone: comparison with amiodarone.

Authors:  Sven Kathofer; Dierk Thomas; Christoph A Karle
Journal:  Cardiovasc Drug Rev       Date:  2005

2.  Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators.

Authors:  E L Pritchett; R L Page; S J Connolly; S R Marcello; D J Schnell; W E Wilkinson
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

3.  Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone.

Authors:  Wei Sun; Jonnalagedda S M Sarma; Bramah N Singh
Journal:  J Cardiovasc Pharmacol       Date:  2002-05       Impact factor: 3.105

4.  Increased mortality after dronedarone therapy for severe heart failure.

Authors:  Lars Køber; Christian Torp-Pedersen; John J V McMurray; Ole Gøtzsche; Samuel Lévy; Harry Crijns; Jan Amlie; Jan Carlsen
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

5.  Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the beta-adrenoceptor and adenylate cyclase in rat heart.

Authors:  P Chatelain; L Meysmans; J R Mattéazzi; P Beaufort; M Clinet
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

6.  Effect of dronedarone on cardiovascular events in atrial fibrillation.

Authors:  Stefan H Hohnloser; Harry J G M Crijns; Martin van Eickels; Christophe Gaudin; Richard L Page; Christian Torp-Pedersen; Stuart J Connolly
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

Review 7.  Dronedarone: an amiodarone analogue.

Authors:  Sheila A Doggrell; Jules C Hancox
Journal:  Expert Opin Investig Drugs       Date:  2004-04       Impact factor: 6.206

8.  Dronedarone for prevention of atrial fibrillation: a dose-ranging study.

Authors:  Paul Touboul; Josep Brugada; Alessandro Capucci; Harry J G M Crijns; Nils Edvardsson; Stefan H Hohnloser
Journal:  Eur Heart J       Date:  2003-08       Impact factor: 29.983

9.  Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.

Authors:  Jean-Marc Davy; Martin Herold; Christer Hoglund; Alphons Timmermans; Antonio Alings; David Radzik; Louis Van Kempen
Journal:  Am Heart J       Date:  2008-09       Impact factor: 4.749

10.  Dronedarone: a new antiarrhythmic agent.

Authors:  Karolina M Zareba
Journal:  Drugs Today (Barc)       Date:  2006-02       Impact factor: 2.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.